Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets open in 40 minutes

S&P Futures
6,022.50
+16.00(+0.27%)
Dow Futures
44,703.00
-123.00(-0.27%)
Nasdaq Futures
20,947.00
+66.75(+0.32%)
Russell 2000 Futures
2,441.80
-9.20(-0.38%)
Crude Oil
69.57
+0.63(+0.91%)
Gold
2,632.40
+13.90(+0.53%)

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

59.03

+1.49

(+2.59%)

At close: 04:00PM EST

58.81

-0.22

(-0.37%)

Pre-Market:

08:41AM EST

Trade prices are not sourced from all markets

Previous Close	57.54
Open	57.62
Bid	58.89 x 100
Ask	59.19 x 100
Day's Range	57.50 - 59.53
52 Week Range	20.84 - 61.66
Volume	1,392,443
Avg. Volume	976,482

Market Cap	6.185B
Beta (5Y Monthly)	0.46
PE Ratio (TTM)	46.85
EPS (TTM)	1.26
Earnings Date	Feb 13, 2025 - Feb 17, 2025
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	74.90

All

Zacks
Why Corcept Therapeutics (CORT) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
  Zacks
- Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
  Zacks
Zacks
Corcept Shares Rise More Than 60% in Three Months: Here's Why
CORT's Cushing's syndrome drug, Korlym, is driving revenues. The NDA for relacorilant in Cushing's syndrome will be filed shortly.